Comera Life Sciences Holdings- Warrants (19/05/2027) Gross Profit

Comera Life Sciences Holdings- Warrants (19/05/2027) (CMRAW) currently reports a gross profit of $740K as of September 2023. That compares with $350K in the prior-year period — up 109.3% year over year. That is below the sector sector average of $750M. Use the charts on this page to explore Comera Life Sciences Holdings- Warrants (19/05/2027)'s gross profit history and peer comparisons.

Comera Life Sciences Holdings- Warrants (19/05/2027)'s gross profit increased from $350K to $740K — a 109.3% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Comera Life Sciences Holdings- Warrants (19/05/2027)'s gross profit of $740K is lower than the its sector sector average of $750M. That is roughly 99.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Comera Life Sciences Holdings- Warrants (19/05/2027) reported $740K in gross profit as of September 2023. That compares with $350K in the prior-year period — up 109.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $740K, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $750M. From there, open related valuation or income-statement pages for Comera Life Sciences Holdings- Warrants (19/05/2027), and consider following CMRAW for alerts when major investors trade the stock.